CompletedPhase 3

The Use of Human Acellular Dermal Matrix to Improve Infraauricular Depressed Deformities and Frey's Syndrome

China70 participantsStarted 2004-01

Plain-language summary

The aim of the study was to explore whether human acellular dermal matrix (ADM) implantation could prevent infraauricular depressed deformities and Frey's syndrome following total parotidectomy.

Who can participate

Age range10 Years – 79 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (1) a clinical and imaging diagnosis of either a malignant parotid tumor or deep parotid tumor * (2) no previous surgical treatment Exclusion Criteria: * recurrent parotid tumors or patients who had previously undergone unsuccessful surgery

What they're measuring

infraauricular depressed deformities and the presence of gustatory flushing or sweating

Timeframe: from 6 months to 7 years after surgery

Trial details

NCT IDNCT01414790

SponsorWest China Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-01

View on ClinicalTrials.gov More Parotid Tumor trials